Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

Claudin 9 Protein-VLP (CLDN9)

CLDN9 Origine: Humain Hôte: HEK-293 Cells VLP
N° du produit ABIN7488753
  • Antigène Voir toutes Claudin 9 (CLDN9) Protéines
    Claudin 9 (CLDN9)
    Type de proteíne
    VLP
    Origine
    • 5
    • 1
    Humain
    Source
    • 2
    • 2
    • 1
    • 1
    HEK-293 Cells
    Fonction
    Human Claudin-9 / CLDN9 Full Length Protein (VLP)
    Séquence
    Met 1 -Val 217
    Attributs du produit
    Human Claudin-9 Full Length Protein-VLP is expressed from human 293 cells (HEK293). It contains AA Met 1 -Val 217 (Accession # O95484-1).
    niveau d'endotoxine
    1.0 EU per μg
    Top Product
    Discover our top product CLDN9 Protéine
  • Restrictions
    For Research Use only
  • Format
    Liquid
    Buffer
    PBS, Arginine, pH 7.4
    Stock
    -80 °C
    Stockage commentaire
    -70°C
  • Antigène
    Claudin 9 (CLDN9)
    Autre désignation
    Claudin-9 (CLDN9 Produits)
    Synonymes
    CLDN9 Protein, nmf329 Protein, claudin 9 Protein, CLDN9 Protein, Cldn9 Protein
    Sujet
    Claudin-9 belongs to the claudin family. Claudins constitute integral membrane proteins responsible for solute and electrolyte permeability of the tight junction that serve as a physical barrier to prevent solutes and water from passing freely through the paracellular space between epithelial or endothelial cell sheets. Tight junctions also play a critical role in maintaining cell polarity and signal transductions. Claudin-9 creates charge specific channels in the paracellular space, plays a major role in tight junction-specific obliteration of the intercellular space, through calcium-independent cell-adhesion activity, is required to preserve sensory cells in the hearing organ because claudin-9-defective tight junctions fail to shield the basolateral side of hair cells from the K+-rich endolymph. Its ion barrier function is essential in the cochlea, but appears to be dispensable in other organs. Is one of the entry cofactors for hepatitis C virus, it enables HCV entry into target cells just as efficiently as CLDN1.
    Pathways
    Cell-Cell Junction Organization, Hepatitis C
Vous êtes ici: